Human neural stem cell tropism to metastatic breast cancer

Stem Cells

Volumn 30, Issue 2, 2012, Pages 314-325

  Zhao, Donghong ^a   Najbauer, Joseph ^a   Annala, Alexander J ^a   Garcia, Elizabeth ^a   Metz, Marianne Z ^a   Gutova, Margarita ^a   Polewski, Monika D ^a   Gilchrist, Megan ^a,b   Glackin, Carlotta A ^a   Kim, Seung U ^c,d   Aboody, Karen S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Chung Ang University College of Medicine   (South Korea)

Author keywords

Breast cancer metastasis; Cancer invasion; Carboxylesterase; CPT 11; Cytokines; Gene therapy; Interleukin 6; Neural stem cells; siRNA; Stem cell tropism; Stem cell mediated therapy

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CARBOXYLESTERASE; INTERLEUKIN 6; INTERLEUKIN 8; IRINOTECAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; FEMUR; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MOUSE; NEURAL STEM CELL; NONHUMAN; SENSITIVITY ANALYSIS; TROPISM; TUMOR LOCALIZATION; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOTRANSFORMATION; CAMPTOTHECIN; CARBOXYLESTERASE; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEURAL STEM CELLS; PRODRUGS; RABBITS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; ORYCTOLAGUS CUNICULUS;

EID: 84862916213     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.784     Document Type: Article

References (43)

1. Lin SX, Chen J, Mazumdar M et al. Molecular therapy of breast cancer: Progress and future directions. Nat Rev 2010;6:485-493.
2. Alvarez RH. Present and future evolution of advanced breast cancer therapy. Breast Cancer Res 2010;12 (suppl 2):S1.
3. Lockman PR, Mittapalli RK, Taskar KS et al. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin Cancer Res 2010;16:5664-5678.
4. Vincent-Salomon A, Bidard FC, Pierga JY. Bone marrow micrometastasis in breast cancer: Review of detection methods, prognostic impact and biological issues. J Clin Pathol 2008;61:570-576.
5. Aboody KS, Brown A, Rainov NG et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000;97:12846-12851.
6. Benedetti S, Pirola B, Pollo B et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2000;6:447-450.
7. Najbauer J, Danks MK, Schmidt NO, et al. Neural stem cell-mediated therapy of primary and metastatic solid tumors. In: Bertolotti R, Ozawa K, eds. Progress in Gene Therapy, Autologous and Cancer Stem Cell Gene Therapy. Singapore: World Scientific, 2007:335-372.
8. Aboody KS, Najbauer J, Schmidt NO et al. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol 2006;8:119-126.
9. Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 2008;15:739-752.
10. Danks MK, Yoon KJ, Bush RA et al. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res 2007;67:22-25.
11. Kim SU. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 2004;24:159-171.
12. Kim SU, Nakagawa E, Hatori K et al. Production of immortalized human neural crest stem cells. Methods Mol Biol 2002;198:55-65.
13. Saltz L. Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer. Oncology 2000;14:47-50.
14. Tanaka A, Aragane N, Komiya K et al. A pilot study of irinotecan hydrochloride(CPT-11)and cisplatin(CDDP)combination chemotherapy for previously treated non-small cell lung cancer. Gan To Kagaku Ryoho 2008;35:49-53.
15. Perez EA, Hillman DW, Mailliard JA et al. Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both. J Clin Oncol 2004;22:2849-2855.
16. Kawato Y, Aonuma M, Hirota Y et al. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 1991;51:4187-4191.
17. Danks MK, Morton CL, Krull EJ et al. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy. Clin Cancer Res 1999;5:917-924.
18. Potter PM, Pawlik CA, Morton CL et al. Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11). Cancer Res 1998;58:2646-2651.
19. Kim SK, Kim SU, Park IH et al. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 2006;12:5550-5556.
20. Jenkins DE, Hornig YS, Oei Y et al. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res 2005;7:R444-454.
21. Morton CL, Iacono L, Hyatt JL et al. Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice. Cancer Chemother Pharmacol 2005;56:629-636.
22. Skehan P, Storeng R, Scudiero D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-1112.
23. Weil RJ, Palmieri DC, Bronder JL et al. Breast cancer metastasis to the central nervous system. Am J Pathol 2005;167:913-920.
24. Weigelt B, Peterse JL, van't Veer LJ. Breast cancer metastasis: Markers and models. Nat Rev Cancer 2005;5:591-602.
25. Akhtari M, Mansuri J, Newman KA et al. Biology of breast cancer bone metastasis. Cancer Biol Ther 2008;7:3-9.
26. Moore S. Managing treatment side effects in advanced breast cancer. Semin Oncol Nurs 2007;23:S23-S30.
27. Loebinger MR, Eddaoudi A, Davies D et al. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res 2009;69:4134-4142.
28. Kidd S, Spaeth E, Dembinski JL et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 2009;27:2614-2623.
29. Frank RT, Edmiston M, Kendall SE et al. Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies. PLoS ONE 2009;4:e8314.
30. Rachakatla RS, Pyle MM, Ayuzawa R et al. Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs. Cancer Investig 2008;26:662-670.
31. Joo KM, Park IH, Shin JY et al. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. Mol Ther 2009;17:570-575.
32. Seol HJ, Jin J, Seong DH et al. Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer. Cancer Lett311:152-159.
33. Sheridan C, Kishimoto H, Fuchs RK et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Res 2006;8:R59.
34. Wang X, Osada T, Wang Y et al. CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer. J Natl Cancer Inst 2010;102:1496-1512.
35. Subik K, Lee JF, Baxter L et al. The expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer 2010;4:35-41.
36. Widera D, Holtkamp W, Entschladen F et al. MCP-1 induces migration of adult neural stem cells. Eur J Cell Biol 2004;83:381-387.
37. Sun L, Lee J, Fine HA. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J Clin Invest 2004;113:1364-1374.
38. Zhao D, Najbauer J, Garcia E et al. Neural stem cell tropism to glioma: Critical role of tumor hypoxia. Mol Cancer Res 2008;6:1819-1829.
39. Kendall SE, Najbauer J, Johnston HF et al. Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling. Stem Cells 2008;26:1575-1586.
40. Heese O, Disko A, Zirkel D et al. Neural stem cell migration toward gliomas in vitro. Neuro Oncol 2005;7:476-484.
41. Schmidt NO, Przylecki W, Yang W et al. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial rowth factor. Neoplasia 2005;7:623-629.
42. DeMichele A, Martin AM, Mick R et al. Interleukin-6-174G→C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res 2003;63:8051-8056.
43. Yokoe T, Iino Y, Morishita Y. Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: Preliminary report. Breast Cancer 2000;7:187-190.